J.E. Tomaszewski
Publications by Year
Research Areas
Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, Legal and Regulatory Analysis, Linguistic, Cultural, and Literary Studies, Military Technology and Strategies
Most-Cited Works
- → Annexin-V imaging for noninvasive detection of cardiac allograft rejection(2001)319 cited
- → Calculated prostate cancer volume greater than 4.0 cm3 identifies patients with localized prostate cancer who have a poor prognosis following radical prostatectomy or external-beam radiation therapy.(1998)25 cited
- → Resolution of nephrotic syndrome after successful bariatric surgery in patient with biopsy-proven FSGS(2009)22 cited
- → Cytopathology of retrograde renal pelvis brush specimens: An analysis of 40 cases with emphasis on collecting duct carcinoma and low-intermediate grade transitional cell carcinoma(1996)19 cited
- → Natural killer-cell activity in cyclosporine-treated renal allograft recipients(1988)17 cited
- → 2155 Identifying patients likely to derive a survival benefit from the use of dose escalation techniques using the prostate-specific antigen level, biopsy gleason score and clinical T-stage(1999)2 cited
- → 1002 Equivalent 5 year bNED in select prostate cancer patients managed with surgery or radiation therapy despit exclusion of the seminal vesicles from the clinical target volume(1997)1 cited
- → 493 Creating Clinical Target Validation Groups Via Quality Assured Transfer of Robust Clinical Pharmacodynamic (PD) Assays From the National Cancer Institute(2012)
- 治療前前立腺特異抗原(PSA)値4-20ナノグラム/1ミリリットルの患者における手術または放射線療法後3年のPSA治療奏効維持生存率の最適予測因子 | 文献情報 | J-GLOBAL 科学技術総合リンクセンター(1998)
- 治療前前立腺特異抗原(PSA)値4-20ナノグラム/1ミリリットルの患者における手術または放射線療法後3年のPSA治療奏効維持生存率の最適予測因子(1998)